APIDRA*
Manufacturer Details
SANOFI AVENTIS
SANOFI INDIA LTD
SANOFI HOUSE, CTS NO 117-B
L&T BUSINESS PARK
SAKI VIHAR ROAD, POWAI
ANDHERI EAST, MUMBAI 400072
Compositions:
Insulin Glulisine rDNA Origin - 100units/ml injection,
|
Strength
|
Rate
|
Packing Style
|
|
100units/ml inj
|
0.00
|
in 10ml vials and 3ml cartridges systen
|
List of Related Indications:
List Of Drugs:
- Insulin Glulisine ( rDNA Origin ) - Antidiabetic Agents
Indication Type Description:
Indication:
Diabetes mellitus-
Dosages/ Overdosage Etc:
Indication-
Diabetes mellitus-
Dosage-
Insulin glulisine is a recombinant insulin that has been shown to be equipotent, to human insulin.One unit of insulin glulisine has the same glucose-lowering effect as 1 unit of regular human insulin when given intravenously.
When given subcutaneously, insulin glulisine has a more rapid onset and shorter duration of
action than regular human insulin
The dosage of insulin should be individualised . Blood monitoring is essenial in all patients
receiving insulin therapy
The total daily requirements may vary and is usually between 0.5 and 1 unit/kg/day.
Insulin requirements may be altered during stress, major illness, or change in excercise.
meal patterns, or coadministered drugs
Insulin glulisine should be given with 15 minutes before a meal or within 20 minutes after
the start of the meal
Interaction with Food:
Insulin glulisine should be given with 15 minutes before a meal or within 20 minutes after
the start of the meal
